The ductus arteriosus is a normal vessel in the fetus that connects the pulmonary artery and the aorta. It allows the fetal blood flow to bypass the lungs, which are not used in utero. The ductus ...

Similar rates of survival without severe morbidity versus placebo in PDA trial ...

“This position statement represents a collective effort between neonatology, anesthesia, and interventional cardiology to provide comprehensive guidance on tcPDA device occlusion that can be adapted ...

Every year, 40,000 babies are born with congenital heart disease. About 1 in 4 of those infants has a life-threatening condition that affects how the heart is shaped, how it works, or both. Now, for ...

Results reinforce that Amplatzer Piccolo™ Occluder is safe and effective for closing an opening in the heart known as a "patent ductus arteriosus" (PDA) in newborns Study found low adverse event rates ...

The Society for Cardiovascular Angiography and Interventions has released a position statement outlining best practices for transcatheter patent ductus arteriosus (PDA) closure in premature infants.

First and only delivery system designed specifically for premature infants with a patent ductus arteriosus (PDA), a life-threatening opening in their heart New delivery system enables precise ...

The Uganda Heart Institute (UHI) has successfully performed five closed-heart surgeries - free of charge — to correct Patent Ductus Arteriosus (PDA), a congenital heart defect. Every year, UHI ...

NICE has produced information for the public on this procedure. It explains the nature of the procedure and the guidance issued by NICE, and has been written with patient consent in mind.